Novel 3-phenylpropanoic acid compounds have the general formula (I) below:
and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or, alternatively, into cosmetic compositions.
新型的3-
苯丙酸衍
生物具有以下的通式(I):
并且这些衍
生物被制成药物组合物,用于人类或兽医学的治疗(在皮肤科、心血管疾病、免疫疾病和/或脂质代谢相关疾病领域),或者制成化妆品组合物。